Video Experimental Relacionado
Updated: Feb 26, 2026
06:24
Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
Published on: January 10, 2025
1.6K
Individuos transgénero y riesgo cardiovascular: lo que el cardiólogo debe saber
Antonia Mannarini1, Maria Teresa Manes2, Giuseppe Ciliberti3
1U.O.C. Cardiologia Ospedaliera, A.O.U. Policlinico, Bari.
Giornale italiano di cardiologia (2006)
|February 25, 2026
Resumen
El riesgo cardiovascular en personas transgénero requiere atención especial debido a las terapias hormonales y los factores sociales. Esta revisión tiene como objetivo mejorar la atención basada en la evidencia y la igualdad de salud para las personas transgénero en relación con las enfermedades cardiovasculares.
Área de la Ciencia:
- Cardiología
- Endocrinología
- Salud Pública
Sus antecedentes:
- La evaluación del riesgo cardiovascular en poblaciones transgénero está poco investigada.
- Las terapias hormonales, las desigualdades sociales y la discriminación impactan la salud cardiovascular de las personas transgénero.
- Existe evidencia limitada sobre los factores de riesgo cardiovascular únicos en personas transgénero en comparación con personas cisgénero.
Objetivo del estudio:
- Revisar el conocimiento actual sobre las enfermedades cardiovasculares en personas transgénero.
- Promover un enfoque basado en la evidencia para la atención cardiovascular de las personas transgénero.
- Avanzar en la equidad en salud en el manejo de las enfermedades cardiovasculares para esta población.
Principales métodos:
- Revisión de la literatura de estudios existentes sobre la salud cardiovascular de las personas transgénero.
- Síntesis de datos sobre los efectos de la terapia hormonal, determinantes sociales y estrés.
- Análisis de los factores de riesgo cardiovascular actuales en las poblaciones transgénero.
Principales resultados:
- Las terapias hormonales pueden influir en los perfiles de riesgo cardiovascular.
- Las desigualdades sociales y el estrés crónico son factores significativos.
- Los modelos actuales de riesgo cardiovascular pueden no aplicarse completamente a las personas transgénero.
Conclusiones:
- Se necesita un enfoque basado en la evidencia para la salud cardiovascular de las personas transgénero.
- Abordar los determinantes sociales es crucial para reducir el riesgo cardiovascular.
- Lograr la equidad en salud requiere estrategias de manejo de enfermedades cardiovasculares personalizadas.
Videos de Conceptos Relacionados
01:27Psychoneuroimmunology: Cardiovascular Disease
612
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
612
01:30Coronary Artery Disease I: Introduction
1.3K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.3K
01:23Assessment of the Cardiovascular System I: Subjective Data
976
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
976
01:20Exercise and Cardiovascular Response
4.7K
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
4.7K
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
979
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
979
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
555
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
555